PDGFRA and gastrointestinal stromal tumor: As SDHX and KIT/PDGFRA mutations are generally considered to be mutually exclusive oncogenic events in GIST, we explored this phenomenon further by screening a panel of ~75 GIST cases with known genotype status from our institution.